Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America, as represented by the Secretary, Department of Health”

1,166 pharma patents match "The United States of America, as represented by the Secretary, Department of Health" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,166
Index total 30,257
Page 47 / 49

Quick answer

This filtered view shows 1,166 pharmaceutical patents matching "The United States of America, as represented by the Secretary, Department of Health" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,166 results for “The United States of America, as represented by the Secretary, Department of Health” · 30,257 patents in full index Clear search

  1. US 8247225

    DNA promoters and anthrax vaccines

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 21, 2012 · Expires Aug 16, 2032

    granted

  2. US 8242160

    Inhibitors of ubiquitin E1

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 14, 2012 · Expires Aug 9, 2032

    granted

  3. US 8227417

    HMGN polypeptides as immune enhancers and HMGN antagonists as immune suppressants

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 24, 2012 · Expires Jul 19, 2032

    granted

  4. US 8227443

    Silencing of CSN5 gene expression using interfering RNA

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 24, 2012 · Expires Jul 19, 2032

    granted

  5. US 8217158

    Immunotoxin fusion proteins and means for expression thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 10, 2012 · Expires Jul 5, 2032

    granted

  6. US 8211422

    Chimeric receptor genes and cells transformed therewith

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted

  7. US 8202551

    Tissue engineered cartilage, method of making same, therapeutic and cosmetic surgical applications using same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 19, 2012 · Expires Jun 14, 2032

    granted

  8. US 8202520

    Method of immunizing humans against Salmonella typhi using a Vi-rEPA conjugate vaccine

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 19, 2012 · Expires Jun 14, 2032

    granted

  9. US 8198402

    Smoothened polypeptides and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 12, 2012 · Expires Jun 7, 2032

    granted

  10. US 8188055

    Inactivators of O6-alkylguanine-DNA alkyltransferase

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 29, 2012 · Expires May 24, 2032

    granted

  11. US 8178508

    Methods of stimulating an immune response against prostate specific antigen

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 15, 2012 · Expires May 10, 2032

    granted

  12. US 8173123

    Methods of treating colitis involving IL-13 and NK-T cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 8, 2012 · Expires May 3, 2032

    granted

  13. US 8153781

    Dendrimer conjugates of agonists and antagonists of the GPCR superfamily

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 10, 2012 · Expires Apr 5, 2032

    granted

  14. US 8147840

    Human immunodeficiency virus (HIV) immunization strategies employing conformationally-stabilized, surface-occluded peptides comprising a gp41 2F5 epitope in association with lipid

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 3, 2012 · Expires Mar 29, 2032

    granted

  15. US 8125225

    Transmit profile control in MRI

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 28, 2012 · Expires Feb 23, 2032

    granted

  16. US 8110192

    Human immunodeficiency virus type 1 (HIV-1)-neutralizing human single-chain antibodies with improved breadth and potency

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 7, 2012 · Expires Feb 2, 2032

    granted

  17. US 8110681

    Compounds for the treatment of spinal muscular atrophy and other uses

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 7, 2012 · Expires Feb 2, 2032

    granted

  18. US 8110352

    Method of diagnosing and treating cancer using B-catenin splice variants

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 7, 2012 · Expires Feb 2, 2032

    granted

  19. US 8093343

    Nitric oxide-releasing diazeniumdiolated compounds

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 10, 2012 · Expires Jan 5, 2032

    granted

  20. US 8088729

    Anti-viral griffithsin compounds, compositions and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 3, 2012 · Expires Dec 29, 2031

    granted

  21. US 8088787

    Methods related to the treatment of neurodegenerative and inflammatory conditions

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 3, 2012 · Expires Dec 29, 2031

    granted

  22. US 8075900

    Melanoma associated peptide analogues and vaccines against melanoma

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 13, 2011 · Expires Dec 8, 2031

    granted

  23. US 8071746

    Isolated nucleic acid molecule encoding a peptide or peptide analog comprising the SEQ ID No. 3

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted

  24. US 8048427

    Subgenomic replicons of the flavivirus dengue

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 1, 2011 · Expires Oct 27, 2031

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.